» Articles » PMID: 8161790

Mutations of the N-ras Gene in Juvenile Chronic Myelogenous Leukemia

Overview
Journal Blood
Publisher Elsevier
Specialty Hematology
Date 1994 Apr 15
PMID 8161790
Citations 25
Authors
Affiliations
Soon will be listed here.
Abstract

Juvenile chronic myelogenous leukemia (JCML), a myeloproliferative disorder of childhood, is distinct from adult-type chronic myelogenous leukemia (CML) and bears resemblance to chronic myelomonocytic leukemia (CMMoL). Since mutations in the N-ras gene have been found at high frequencies in CMMoL, but only rarely in CML, we analyzed mutations activating the N-ras gene in 20 patients with JCML. We used the strategy for analysis of gene mutations based on in vitro DNA amplification by polymerase chain reaction (PCR) followed by single-strand conformation polymorphism (SSCP) analysis and/or direct sequence analysis. Nucleotide sequence analysis showed single nucleotide substitutions involving codons 12, 13, or 61 in six of 20 patients (30%). Four of six patients with mutations were in chronic phase and the other two in blast crisis, indicating no apparent correlation with disease stage. Most of the patients with mutations were in the older age group with poor prognosis, although one patient in the younger age group also harbored the mutation. These data suggest that N-ras gene mutations may be involved in the pathogenesis and/or prognosis of JCML and provide further evidence that JCML is an entity distinct from CML.

Citing Articles

Targeting few to help hundreds: JAK, MAPK and ROCK pathways as druggable targets in atypical chronic myeloid leukemia.

Rocca S, Carra G, Poggio P, Morotti A, Brancaccio M Mol Cancer. 2018; 17(1):40.

PMID: 29455651 PMC: 5817721. DOI: 10.1186/s12943-018-0774-4.


Long-term serial xenotransplantation of juvenile myelomonocytic leukemia recapitulates human disease in Rag2-/-γc-/- mice.

Krombholz C, Aumann K, Kollek M, Bertele D, Fluhr S, Kunze M Haematologica. 2016; 101(5):597-606.

PMID: 26888021 PMC: 5004370. DOI: 10.3324/haematol.2015.138545.


JMML and RALD (Ras-associated autoimmune leukoproliferative disorder): common genetic etiology yet clinically distinct entities.

Calvo K, Price S, Braylan R, Oliveira J, Lenardo M, Fleisher T Blood. 2015; 125(18):2753-8.

PMID: 25691160 PMC: 4424627. DOI: 10.1182/blood-2014-11-567917.


Criteria for evaluating response and outcome in clinical trials for children with juvenile myelomonocytic leukemia.

Niemeyer C, Loh M, Cseh A, Cooper T, Dvorak C, Chan R Haematologica. 2015; 100(1):17-22.

PMID: 25552679 PMC: 4281308. DOI: 10.3324/haematol.2014.109892.


RAS diseases in children.

Niemeyer C Haematologica. 2014; 99(11):1653-62.

PMID: 25420281 PMC: 4222471. DOI: 10.3324/haematol.2014.114595.